Daniel E. Singer

Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

In patients with atrial fibrillation, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism. There was no significant between-group differenc...

Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

In a large, contemporary cohort of ambulatory patients with atrial fibrillation who received care within a health maintenance organization, warfarin use was considerably higher ...

Antithrombotic Therapy in Atrial Fibrillation

A Prediction Rule to Identify Low-Risk Patients with Community-Acquired Pneumonia

The prediction rule we describe accurately identifies the patients with community-acquired pneumonia who are at low risk for death and other adverse outcomes. This prediction ru...